Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000919574-07-001497
Filing Date
2007-02-22
Accepted
2007-02-22 15:08:46
Documents
1

Document Format Files

Seq Description Document Type Size
1 d749895_13-g.txt SC 13G 13688
  Complete submission text file 0000919574-07-001497.txt   15582
Mailing Address 152 WEST 57TH STREET 50 FLOOR NEW YORK NY 10019
Business Address 157 WEST 57TH STREET 50TH FLOOR NEW YORK NY 10019 2123330100
KINGDON CAPITAL MANAGEMENT LLC (Filed by) CIK: 0001000097 (see all company filings)

Type: SC 13G

Mailing Address 1110 SPRING ST SILVER SPRING MD 20910
Business Address 1110 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS CORP (Subject) CIK: 0001082554 (see all company filings)

EIN.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-57843 | Film No.: 07641924
SIC: 2834 Pharmaceutical Preparations